Skip to content

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو | English

facebook-square
x
envelope

Menu

About Us
Therapeutic Goods
Safety Info
News & Updates
Publications
E-Services
Medicine Availability
Support

Home > About Us > Legislation > Notifications > Draft Therapeutic Goods (Federal Inspectors, Federal Government Analysts and Federal Quality Control Laboratories) Rules, 2026 (11.11.2026)

Draft Therapeutic Goods (Federal Inspectors, Federal Government Analysts and Federal Quality Control Laboratories) Rules, 2026 (11.11.2026)

Ijaz Mustafa Notifications November 11, 2026November 11, 2026

Draft Therapeutic Goods (Federal Inspectors, Federal Government Analysts and Federal Quality Control Laboratories) Rules, 2026 (11.11.2026)Download

Share this:

LinkedIn
WhatsApp
Facebook
X

← Conducting a Study to Assess the Impact of De-Regulation of Prices of Drugs on Pharmaceutical Sector

DRAP at a Glance
Organization
Legislation
- Acts
- Rules
- Regulations
- SROs
- Notifications
Boards and Committees
Quality Management System
- Quality Policy
- Management Reviews

Quick Navigation

Quick Navigation

Registered Drugs Index
Drug Pricing Index
List of Pharmaceutical Units

Archives

Archives

Drug Regulatory Authority of Pakistan

Islamabad | Karachi | Lahore | Peshawar | Quetta
Phone: 0800-03727 (Mon to Fri 08:00AM to 04:00PM)
Website: www.dra.gov.pk

Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan

Contact Us
Report a Problem

<
<